Show simple item record

dc.contributor.authorAcebedo-Martínez, Francisco J.
dc.contributor.authorAlarcón Payer, Carolina
dc.contributor.authorDomínguez Martín, Alicia 
dc.contributor.authorFrontera, Antonio
dc.contributor.authorProhens, Rafel
dc.contributor.authorBarbas, Rafael
dc.contributor.authorChoquesillo Lazarte, Duane
dc.date.accessioned2025-10-26T06:32:55Z
dc.date.available2025-10-26T06:32:55Z
dc.date.issued2025-10-07
dc.identifier.citationAcebedo-Martínez, F. J., Alarcón-Payer, C., Domínguez-Martín, A., Frontera, A., Prohens, R., Barbas, R., & Choquesillo-Lazarte, D. (2025). Exploring sublimation as a tool for polymorphic screening in niflumic acid–caffeine pharmaceutical cocrystals. Crystal Growth & Design, acs.cgd.5c01007. https://doi.org/10.1021/acs.cgd.5c01007es_ES
dc.identifier.urihttps://hdl.handle.net/10481/107439
dc.description.abstractSublimation has emerged as a powerful tool for polymorphic screening in pharmaceutical multicomponent materials. In this work, a combined strategy involving mechanochemistry and sublimation enables the selective synthesis and isolation of a novel polymorph (Form III) of the niflumic acid−caffeine (NIF− CAF) cocrystal. Solid-state characterization and complementary theoretical studies revealed that Form III is morphotropically related to Form II, sharing a similar molecular conformation with the −COOH and −CF3 groups positioned on the same side of the NIF molecule. However, Form III exhibits a distinct packing arrangement, featuring embedded −CF3 groups and alternating molecular tapes stabilized by π−π and F···F interactions. Thermal analysis also indicates an enantiotropic relationship between Forms II and III, with Form III becoming the more stable phase above the estimated transition temperature of ∼102 °C, and showing a melting point of 156 °C. These findings demonstrate the relevance of sublimation in polymorphic screening and its potential to expand the solid-state landscape of multicomponent materials with enhanced control and reproducibilityes_ES
dc.description.sponsorshipMCIU/AEI/10.13039/501100011033 and ERDF – (Grants PID2023-151538NB-I00, PID2023-146632OB-I00, PID2023-148453NB-I00)es_ES
dc.language.isoenges_ES
dc.publisherAmerican Chemical Societyes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleExploring Sublimation as a Tool for Polymorphic Screening in Niflumic Acid−Caffeine Pharmaceutical Cocrystalses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1021/acs.cgd.5c01007
dc.type.hasVersionVoRes_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional